In a move set to reshape the landscape of clinical research technology, Thermo Fisher Scientific Inc. announced Wednesday that it will acquire Clario Holdings Inc. from a consortium led by Astorg, Nordic Capital, Novo Holdings, and Cinven for $8.875 billion in cash. The all-cash acquisition will deepen Thermo Fisher’s foothold in digital clinical trial solutions Thermo Fisher to acquire Clario in $8.9B cash deal to expand AI-driven clinical data capabilities.
In a move set to reshape the landscape of clinical research technology, Thermo Fisher Scientific Inc. announced Wednesday that it will acquire Clario Holdings Inc. from a consortium led by Astorg, Nordic Capital, Novo Holdings, and Cinven for $8.875 … [861 chars]
Source: USA Herald | Published: 2025-10-29T17:10:34Z
Credit: USA Herald
